Chemical Synthesis of Ubiquitin, Ubiquitin-Based Probes, and Diubiquitin** by El Oualid, Farid et al.
Protein Modification
DOI: 10.1002/anie.201005995
Chemical Synthesis of Ubiquitin, Ubiquitin-Based Probes, and
Diubiquitin**
Farid El Oualid, Remco Merkx, Reggy Ekkebus, Dharjath S. Hameed, Judith J. Smit,
Annemieke de Jong, Henk Hilkmann, Titia K. Sixma, and Huib Ovaa*
Post-translational modification of proteins with ubiquitin
(Ub) and Ub chains controls protein breakdown by the
proteasome, cellular localization of proteins, transcriptional
activity, and DNA repair.
[1] Ubiquitin is a highly conserved 76
amino acid protein that can be linked to target proteins
through an isopeptide bond between the C-terminal carbox-
ylate of Ub and the e-amine of a lysine residue or N terminus
of the target protein. Ubiquitin is able to form chains by self-
conjugation onto any of its seven lysine residues (namely, K6,
K11, K33, K27, K29, K48, and K63). Although all the linkages
have been identified in cells,
[2] only K48 and K63 linkages
have been thoroughly studied so far. The conjugation of
ubiquitin requires the concerted action of E1, E2, and E3
enzymes, defined combinations of which provide specificity
for the protein target and the nature of the Ub chain
topoisomers. The E1 enzyme initiates the cascade by activat-
ing Ub at the expense of ATP to form an E1-Ub thioester
between the cysteine residue of the E1 active site and the C-
terminal carboxylate of Ub. This E1-Ub thioester serves as a
donor of activated Ub that then enters the complex enzymatic
conjugation cascade.
The ability to generate Ub polymers biochemically is
currently limited to the generation of K11, K48, and K63
topoisomers,
[3] a strategy that requires prior identification and
production of specific E2 enzymes.
[4] Moreover, the gener-
ation of Ub mutants by biochemical methodsis largely limited
by the repertoire of natural amino acids. Therefore, reliable
routes towards site-specifically labeled Ub derivatives, Ub-
based reagents, and conjugates are needed to provide the
scientific community with the research reagents they need.
Methods for the chemical synthesis of Ub have already
been reported. Recent modular procedures based on the
ligation of segments provide the best overall yields.
[5a,b]
However, the modular character introduces extensive purifi-
cation procudures, thus making the procedures unsuitable for
the automated parallel generation of reagents. Previously
reported linear Fmoc-based (Fmoc=9-fluorenylmethoxycar-
bonyl) syntheses
[5c–h] of Ub led to low yields (4%) and
modest purity at best. Several (semisynthetic) strategies
towards Ub have been reported that allow the construction
of isopeptide-linked Ub conjugates. The first approach
[6] uses
a photolabile auxiliary that assists native chemical ligation
[7]
of a recombinant Ub thioester. Other approaches rely on
thiolysine-based chemical ligation handles,
[8] and afford
native isopeptide linkages after ligation to recombinant Ub
thioester and subsequent desulfurization.
[9] Thiolysine-medi-
ated ligation was also used very recently in segment-based
strategies to construct diubiquitins (diUb),
[10ab] while K6- and
K29-linked diUbs were obtained by a strategy that relies on a
genetic code expanded to the incorporation of N
e-Boc-lysine
(Boc=tert-butoxycarbonyl).
[10c] In addition, various
approaches towards isosteres of Ub isopeptide conjugates
have been reported recently.
[11]
Despite all the developments mentioned, more powerful
andrapid approachesare stillneeded toobtain Ub derivatives
and conjugates in sufficient quantities. Therefore, we have
developed a high-yielding Fmoc-based linear solid-phase
peptide synthesis (SPPS) of Ub that allows the incorporation
of desired tags and mutations as well as specific C-terminal
modification and the construction of any diUb conjugate in a
straightforward manner. By using this method we have
produced Ub, numerous Ub mutants, and conjugates on a
25 mmol scale with consistent purities and yields over
200 times.
As linear syntheses yield the desired products directly and
in parallel, which is a significant advantage over modular
approaches, we revisited the linear chemical synthesis of Ub.
We decided to investigate the incorporation of pseudoproline
building blocks and dimethoxybenzyl (DMB) dipeptides
(Figure 1A), which prevent the formation of folded and/or
aggregated intermediates on-resin, events that can hamper
cleavage of the Fmoc group and/or further elongation of the
Ub chain.
[12]
We identified six positions in the Ub sequence where such
dipeptide building blocks could be incorporated (Figure 1A,
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building blocks). Using a Wang resin and standard coupling
conditions (namely, 4 equiv Fmoc-protected amino acid,
4 equiv PyBOP, 8 equiv DIPEA, and single coupling
reactions), simultaneous incorporation of all the six
selected building blocks led to the synthesis of Ub in high
yield (54% yield of the crude product) and 14% after
refolding (see the Supporting Information) and purifica-
tion by cation-exchange chromatography (Figure 1). A
control experiment without these dipeptide building blocks
did not give a defined product. Incorporation of the
standard Fmoc amino acids at specific positions (S65T66 or
L56S57) instead of the corresponding pseudoproline build-
ing blocks did afford Ub, but in very low yield. Omission of
any of the other dipeptide building blocks led to an
unproductive synthesis.
Correct folding of the purified synthetic Ub was
verified by circular dichroism (CD) spectroscopy (see the
Supporting Information). To further verify the correct
folding and thus biochemical function we compared synthetic
and recombinant Ub in enzymatic ligation experiments
(Figure 2). This proved that synthetic Ub is incorporated
with the same efficiency as recombinant Ub into different
chain topologies.
With a productive synthesis of Ub in hand, we synthesized
various Ub fusions. His6- and HA epitope-tagged N-terminal
Ub fusions could be generated efficiently, while site-selective
N-terminal modification with various labels provided N-
terminally labeled 5-carboxytetramethylrhodamine-Ub, 5(6)-
carboxyfluorescein-Ub, and DOTA-Ub (DOTA=1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid) conjugates
cleanly and in good yield upon purification (see the Support-
ing Information).
Figure 1. A) Amino acid sequence of Ub containing the set of dipep-
tide building blocks used in our Fmoc-SPPS of Ub; L8T9, I13T14,
L56S57, and S65T66 were replaced by the corresponding pseudopro-
line dipeptide (I), A46G47 and D52G53 were replaced by their
corresponding dimethoxybenzyl dipeptide (II). B) Liquid chromatogra-
phy profile of commercial Ub and C) crude synthetic Ub. D) MS
analysis of crude synthetic Ub, calcd 8565 Da, found: 8565 Da; the
deconvoluted spectrum is shown on the right.
Figure 2. Comparison of the chain-forming capability of synthetic
ubiquitin (left) with expressed ubiquitin (right) evaluated on an anti-
Ub Western blot. The ability to form ubiquitin linkages through
different lysine residues was compared in the presence of E1 and E2
as indicated, and with or without the E3 ligase Triad1. E1=Uba1
(500 nm), various E2s (2 mm); E3=Triad1 (1 mm), Ub (15 mm), ATP
(3 mm), 308C, 2
1= 2 h. In this assay all E2s promote chain formation of
mixed chains (UbcH5c), K48 (E2-25K), K63 (Ubc13 mms2), or K11
linkages (E2S). The reaction with UbcH5c and E2-25K is stimulated by
the presence of the E3 ligase Triad1. Synthetic and expressed ubiquitin
form all ubiquitin chain types equally well.
Scheme 1. A) Synthesis of C-terminally modified Ub. PG=protecting
group. a) HFIP/CH2Cl2, 30 min, RT; b) PyBOP, DIPEA, Nu, CH2Cl2,1 6h ,
RT; c) TFA/iPr3SiH/H2O 3 h, RT. DIPEA=N,N-diisopropylethylamine,
HFIP=1,1,1,3,3,3-hexafluoro-2-propanol, PyBOP=benzotriazol-1-yl-oxytri-
pyrrolidinophosphonium hexafluorophosphate, TFA=trifluoroacetic acid.
B) Turnover of commercial and synthetic UbAMC by USP7 shows identical
Michaelis–Menten kinetics.
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mutants in hand we focused on generating C-terminal Ub
fusions, since the combined set of chemical synthesis, ligation,
and C-terminal modifica-
tion provides entry into
virtually any desired Ub
derivative. For this pur-
pose we synthesized full-
length Ub on a hyper-
acid-labile trityl resin
(Scheme 1) with the N-
terminal methionine resi-
due protected with a Boc
group. Total deprotection
of this product with 95%
TFA gave Ub in the same
purity and yield as the
synthesis on Wang resin.
Protected synthetic
Ub(1-75) with a free C-
terminal carboxylate was
then generated through
selective cleavage from
the resin with 20% hexa-
fluoro-2-propanol in
CH2Cl2.
[13] This product,
which is fully soluble in
neat dichloromethane was
then condensed with
GlyAMC and GlyRhoda-
mine110Gly to yield
UbAMC and
UbRh110Gly in 6% and
5% overall yield, respec-
tively, after deprotection
and purification
(Scheme 1). These Ub
conjugates serve as fluo-
rogenic substrates to mea-
sure the activity of deubi-
quitinating enzymes
(DUBs).
[14] Efficient turn-
over of synthetic UbAMC
and UbRh110Gly was
confirmed upon their
incubation with the
DUBs HAUSP/USP7 and
UCH-L3 (see the Sup-
porting Information). No
significant difference
between the turnover of
the synthetic and commer-
cial UbAMC by HAUSP/
USP7 could be observed,
and identical Michaelis–
Menten constants were
obtained (Scheme 1B).
Next, we investigated
whether we could con-
struct higher order Ub conjugates. For this we chemically
mutated individual lysine residues into d-thiolysine residues.
We incorporated the methyldisulfide-protected d-thiolysine
Figure 3. A) Structure of Fmoc- and methyldisulfide-protected d-thiolysine building block 1. B) Structure of
radical initiators VA-044 and V-50. C) SDS-PAGE analysis of diUb ligation under native conditions by using
in situ E1-generated Ub thioester: 50 mm sodium phosphate buffer pH 8, 6 mm ATP, 6 mm MgCl2,5 0mm Ub,
50 mm Ub K to d-thiolysine/G76 V mutant, 250 nm E1, 50 mm MPAA. D) SDS-PAGE analysis of DiUb ligation
under denaturing conditions: 6m Gdn·HCl pH 8, 10 mgmL
1 UbMESNa, 10 mgmL
1 Ub K to d-thiolysine/
G76 V mutant, 100 mm MPAA, 50 mm TCEP. E) Liquid chromatography trace and F) mass spectrum of purified
K33-linked diUb ligation product (d-thiolysine intermediate). G) The deconvoluted mass spectrum of the ligation
product showed a product with a mass that corresponds to the disulfide product of MPAA and d-thiolysine of
the diUb ligation product. H) Addition of 50 mm TCEP to the purified product gave the free thiol. I) Radical-
mediated desulfurization of the K33-linked diUb ligation product resulted in clean formation of the native K33-
linked diUb. Conditions: 6m Gdn·HCl, 0.1m sodium phosphate (pH 6.5) diUb conjugate (12 mm), 200 mmV-50,
250 mm TCEP, 40 mm glutathione, 608C, overnight incubation.
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for synthetic details) into the Ub sequence to generate all
seven individual lysine to d-thiolysine methyldisulfide
mutants, including a Gly76 to Val mutation to prevent
processing by the E1 enzyme. After refolding and purifica-
tion, mutants were obtained in 6–9% overall yield (see the
Supporting Information).
We investigated the ability of these double mutants to
participate in the formation of diUb topoisomers. We first
focussed on in situ E1-mediated thioester formation and
concomitant native chemical ligation.
[15] Initial reactions
using 2-mercaptoethanesulfonic sodium salt (MESNa) as a
thiol resulted in no detectable ligation. The use of the native
chemical ligation catalyst 4-mercaptophenylpropionic acid
(MPAA),
[16] however, proved effective for the productive
formation of diUb, as evidenced by analysis of the crude
reaction mixture by sodium dodecasulfate polyacrylamide gel
electrophoresis (SDS-PAGE; Figure 3C). Production of K27
and K29 linkages proved difficult, most likely because
residues K27 and K29 are the least accessible lysine residues
in ubiquitin (see the Supporting Information). We therefore
turned our attention to denaturing conditions to ligate
purified ubiquitin thioester onto ubiquitin thiolysine mutants.
We first produced UbMESNa conveniently and in large
quantities through E1-catalyzed transthioesterification of
100 mm Ub (50 mm sodium phosphate buffer pH 8, 500 nm
E1, 10 mm adenosine triphosphate (ATP), 10 mm MgCl2,
100 mm MESNa, 5 h., 378C). Upon completion, the reaction
mixture was acidified and purified, and consistently afforded
ubiquitin thioester in over 80% yield.
After optimization of the ligations under denaturing
conditions, we identified the following general conditions as
the most efficient for the generation of diUb topoisomers on a
preparative scale: UbMESNa and Ub d-thiolysine mutant are
dissolved at 10 mgmL
1 in a 1:1 ratio in the ligation mixture
(6m guanidine hydrochloride (Gdn·HCl) pH 8, 50 mm tris(2-
carboxyethyl)phosphine (TCEP) and 100 mm MPAA) and
incubated overnight at 378C; next an additional amount of
UbMESNa (0.5 equiv) is added to the ligation mixture to
ensure full consumption of all the d-thiolysine mutant. Gels of
the crude ligation reactions are shown in Figure 3D. After
preparative HPLC, the anticipated d-thiolysine-linked diUb
conjugates were isolated as MPAA disulfides in all cases
(Figure 3D–G) on a multimilligram scale in yields ranging
from 35 to 72% (See the Supporting Information).
Attempts at radical-mediated desulfurizations at 378Cb y
using the radical initiator VA-044 (Figure 3B), glutathione
(40 mm), and TCEP (250 mm) proved unsuccessful. Treat-
ment of the K33-linked diUb conjugate (0.5 mg in 2.5 mL 6m
Gdn·HCl in 0.1m sodium phosphate pH 6.5) with the alter-
native radical initiator V-50 (200 mm, Figure 3B), 40 mm
glutathione, and 250 mm TCEP at 608C led to a clean and
complete desulfurization
[9] after incubation overnight (Fig-
ure 3I; see also the Supporting Information). This desulfur-
ization procedure proved applicable on a preparative scale to
all of the remaining linkages (see the Supporting Informa-
tion).
In conclusion, we have shown that the Fmoc-SPPS of Ub
reported here enables the parallel incorporation of desired
tags, labels, and mutations in high yields with high purities. It
also proved possible to introduce C-terminal modifications to
Ub, thereby allowing the synthetic construction of various
Ub-based reagents. This synthetic approach to specifically
labeled derivatives offers significant advantages over the
established intein method,
[14c] which is largely limited to the
natural amino acids. Finally, with our Ub Fmoc-SPPS
methodology we have synthesized all seven possible d-
thiolysine-Ub mutants and used these for the construction
of all diUb topoisomers in a native manner. Recently, three
independent reports described routes to diUb conjugates.
[10]
The straightforward linear synthesis of Ub and Ub mutants
that we describe here, combined with the efficient production
of the UbMESNa thioester, now allows a more convenient
preparation of diUb conjugates. Having routine strategies for
the chemical construction of Ub mutants, Ub chains, or
specific C-terminal modifications, virtually any Ub derivative
is now within practical reach. We believe that the versatility of
the methodsreported herewillacceleratethe paceofresearch
into the biology of Ub, thereby opening novel avenues for
research and drug discovery.
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